Stock listing
BOATS:OBIO Orchestra BioMed Holdings, Inc. Stock
US listing (BOATS) of Orchestra BioMed Holdings, Inc. · home listing NASDAQ:OBIO
Follow Orchestra BioMed Holdings, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:OBIO
$5.68 USD +0.06 (+1.1%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:OBIO
- Day range
- $5.14 – $6.04 USDNov 6, 2026
- Volume
- 1.74M sharesNov 6, 2026
- Market cap
- $341.4M USDAt the close on Nov 6, 2026 · price × 60.11M shares outstanding
- 52-week range
- $3.46 – $6.50 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $2.05M USDMedian day 262,450 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:OBIO · Home | $5.68 USD | +0.06 (+1.1%) | 1,740,882 | $5.135 | $6.04 | $5.135 | $5.62 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:OBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.68 | +0.06 | +1.1% | $5.135 | $6.04 | $5.135 | 1,740,882 | |
| $5.62 | -0.38 | -6.3% | $6.00 | $6.00 | $5.60 | 253,745 | |
| $6.00 | +0.44 | +7.9% | $5.815 | $6.161 | $5.78 | 335,412 | |
| $5.56 | -0.13 | -2.3% | $5.70 | $5.98 | $5.52 | 273,209 | |
| $5.69 | -0.22 | -3.7% | $5.92 | $6.02 | $5.66 | 317,495 | |
| $5.91 | -0.18 | -3.0% | $6.07 | $6.075 | $5.845 | 231,581 | |
| $6.09 | +0.10 | +1.7% | $6.05 | $6.16 | $6.00 | 274,563 | |
| $5.99 | +0.21 | +3.6% | $5.76 | $6.03 | $5.685 | 427,145 | |
| $5.78 | +0.23 | +4.1% | $5.842 | $5.842 | $5.52 | 376,769 | |
| $5.55 | -0.04 | -0.7% | $5.58 | $5.655 | $5.52 | 242,656 | |
| $5.59 | +0.12 | +2.2% | $5.46 | $5.66 | $5.39 | 262,000 | |
| $5.47 | -0.335 | -5.8% | $5.72 | $5.789 | $5.43 | 390,900 | |
| $5.805 | -0.015 | -0.3% | $5.83 | $5.865 | $5.57 | 486,000 | |
| $5.82 | +0.17 | +3.0% | $5.65 | $6.17 | $5.53 | 992,100 | |
| $5.65 | +0.20 | +3.7% | $5.49 | $5.73 | $5.415 | 226,600 | |
| $5.45 | -0.29 | -5.1% | $5.75 | $5.87 | $5.37 | 473,700 | |
| $5.74 | +0.10 | +1.8% | $5.68 | $5.85 | $5.66 | 253,400 | |
| $5.64 | -0.08 | -1.4% | $5.70 | $5.86 | $5.60 | 222,900 | |
| $5.72 | -0.19 | -3.2% | $5.87 | $5.87 | $5.71 | 204,800 | |
| $5.91 | -0.04 | -0.7% | $5.93 | $5.99 | $5.39 | 237,900 | |
| $5.95 | +0.22 | +3.8% | $5.73 | $5.965 | $5.56 | 229,300 | |
| $5.73 | +0.07 | +1.2% | $5.75 | $5.83 | $5.51 | 241,900 | |
| $5.66 | -0.18 | -3.1% | $5.79 | $5.859 | $5.64 | 241,200 | |
| $5.84 | -0.19 | -3.2% | $6.05 | $6.12 | $5.82 | 213,100 | |
| $6.03 | +0.08 | +1.3% | $5.89 | $6.09 | $5.79 | 284,800 | |
| $5.95 | -0.40 | -6.3% | $6.40 | $6.44 | $5.77 | 421,100 | |
| $6.35 | +0.13 | +2.1% | $6.27 | $6.50 | $6.23 | 389,900 | |
| $6.22 | +0.14 | +2.3% | $6.09 | $6.29 | $6.00 | 270,700 | |
| $6.08 | +0.19 | +3.2% | $5.89 | $6.09 | $5.83 | 237,100 | |
| $5.89 | -0.06 | -1.0% | $5.95 | $5.95 | $5.80 | 177,500 | |
| $5.95 | 0.00 | 0.0% | $5.99 | $6.17 | $5.86 | 248,800 | |
| $5.95 | +0.02 | +0.3% | $5.90 | $6.05 | $5.75 | 262,900 | |
| $5.93 | -0.29 | -4.7% | $6.10 | $6.20 | $5.90 | 242,300 | |
| $6.22 | -0.03 | -0.5% | $6.15 | $6.48 | $6.053 | 342,900 | |
| $6.25 | +0.17 | +2.8% | $6.04 | $6.29 | $5.85 | 433,200 | |
| $6.08 | +0.30 | +5.2% | $5.74 | $6.30 | $5.71 | 1,137,400 | |
| $5.78 | -0.23 | -3.8% | $6.03 | $6.26 | $5.73 | 411,200 | |
| $6.01 | -0.03 | -0.5% | $6.05 | $6.28 | $5.93 | 297,200 | |
| $6.04 | +0.14 | +2.4% | $6.00 | $6.13 | $5.93 | 228,400 | |
| $5.90 | -0.22 | -3.6% | $6.07 | $6.20 | $5.74 | 383,500 | |
| $6.12 | +0.31 | +5.3% | $5.87 | $6.25 | $5.76 | 464,400 | |
| $5.81 | +0.36 | +6.6% | $5.845 | $6.08 | $5.68 | 761,500 | |
| $5.45 | +0.02 | +0.4% | $5.31 | $5.46 | $5.261 | 198,600 | |
| $5.43 | +0.35 | +6.9% | $5.18 | $5.51 | $4.80 | 359,300 | |
| $5.08 | +0.34 | +7.2% | $4.71 | $5.14 | $4.71 | 478,100 | |
| $4.74 | -0.21 | -4.2% | $4.97 | $4.97 | $4.71 | 325,600 | |
| $4.95 | +0.05 | +1.0% | $4.92 | $5.01 | $4.83 | 240,400 | |
| $4.90 | -0.14 | -2.8% | $5.02 | $5.349 | $4.875 | 214,500 | |
| $5.04 | -0.145 | -2.8% | $5.23 | $5.33 | $5.004 | 276,600 | |
| $5.185 | +0.075 | +1.5% | $5.23 | $5.23 | $5.06 | 154,500 | |
| $5.11 | -0.15 | -2.9% | $5.23 | $5.42 | $5.10 | 220,500 | |
| $5.26 | -0.10 | -1.9% | $5.36 | $5.45 | $5.16 | 391,700 | |
| $5.36 | -0.08 | -1.5% | $5.37 | $5.50 | $5.35 | 169,600 | |
| $5.44 | +0.08 | +1.5% | $5.35 | $5.48 | $5.21 | 249,500 | |
| $5.36 | -0.07 | -1.3% | $5.45 | $5.53 | $5.27 | 276,700 | |
| $5.43 | -0.12 | -2.2% | $5.53 | $5.58 | $5.38 | 209,600 | |
| $5.55 | -0.11 | -1.9% | $5.492 | $5.78 | $5.49 | 463,800 | |
| $5.66 | +0.94 | +19.9% | $4.74 | $5.77 | $4.69 | 2,063,400 | |
| $4.72 | +0.31 | +7.0% | $4.41 | $4.72 | $4.36 | 221,600 | |
| $4.41 | -0.04 | -0.9% | $4.47 | $4.47 | $4.29 | 142,800 | |
| $4.45 | +0.03 | +0.7% | $4.46 | $4.545 | $4.40 | 226,800 | |
| $4.42 | +0.02 | +0.5% | $4.39 | $4.47 | $4.20 | 207,700 | |
| $4.40 | -0.06 | -1.3% | $4.27 | $4.66 | $4.27 | 345,487 | |
| $4.46 | +0.22 | +5.2% | $4.25 | $4.495 | $4.25 | 166,405 | |
| $4.24 | +0.09 | +2.2% | $4.17 | $4.285 | $4.14 | 103,900 | |
| $4.15 | -0.07 | -1.7% | $4.21 | $4.26 | $4.03 | 149,100 |
- Ticker
- BOATS:OBIO
- Asset type
- Stock
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Orchestra BioMed Announces Pricing of Public Offering
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 30 slides
Latest news
Orchestra BioMed Announces Pricing of Public Offering
Nov 5, 2026
Closed $5.68 (+1.1%) on Nov 6, 2026
Orchestra BioMed Announces Proposed Public Offering
Nov 5, 2026
Closed $5.68 (+1.1%) on Nov 6, 2026
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
Oct 29, 2026
Closed $6.09 (+1.7%) on Oct 29, 2026
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB
Oct 22, 2026
Closed $5.47 (-5.8%) on Oct 22, 2026
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
Oct 1, 2026
Closed $6.35 (+2.1%) on Oct 1, 2026
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
Sep 16, 2026
Closed $6.01 (-0.5%) on Sep 16, 2026
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
Sep 15, 2026
Closed $6.04 (+2.4%) on Sep 15, 2026
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Aug 27, 2026
Closed $5.11 (-2.9%) on Aug 27, 2026
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
Aug 20, 2026
Closed $5.43 (-2.2%) on Aug 20, 2026
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
Aug 10, 2026
Closed $4.40 (-1.3%) on Aug 11, 2026
Financings
Public offering of shares of common stock
Nov 6, 2026
Announced: US$75M · US$5 a share · Piper Sandler +3
Dealers: Piper Sandler (co-lead), TD Cowen (co-lead), BTIG, H.C. Wainwright & Co.
Use of proceeds: Fund AVIM Therapy program and BACKBEAT Trial, Virtue SAB program and Virtue Trial, other R&D, working capital and general corporate purposes
Public offering of shares of common stock
Nov 5, 2026
Announced: Piper Sandler +2
Dealers: Piper Sandler (co-lead), TD Cowen (co-lead), BTIG
Use of proceeds: Fund AVIM Therapy program and BACKBEAT trial, Virtue SAB program and Virtue Trial, other R&D, working capital and general corporate purposes
Strategic investment of strategic capital
Aug 10, 2026
Closed: US$35M raised
Buyers: Medtronic (Medtronic's total capital contribution to Orchestra BioMed is nearly $82 million, including this investment); Ligand (Ligand has now provided $40 million in total capital to the Company)
Strategic investment of non-voting convertible preferred stock
Oct 28, 2025
Announced: US$20M
Buyers: Terumo ($20 million in a new series of non-voting preferred stock)
Use of proceeds: Advance both pivotal stage programs to key clinical and regulatory milestones
Public offering of common stock and pre-funded warrants
Aug 1, 2025
Announced: about US$40M · US$2.75 a share · Piper Sandler +1
Dealers: Piper Sandler (co-lead), TD Cowen (co-lead)
Use of proceeds: Fund AVIM therapy program and BACKBEAT study, Virtue SAB program and trial, other product candidates, working capital and general corporate purposes
Tiered royalty on future sales of AVIM therapy and Virtue SAB
Jul 31, 2025
Announced: US$35M
Buyers: Ligand ($20 million at closing and an additional $15 million at the nine-month anniversary, subject to conditions)
Use of proceeds: To advance its late-stage partnered cardiology programs (AVIM therapy and Virtue SAB)
Private placement of common stock
Jul 31, 2025
Announced: US$5M
Buyers: Ligand ($5 million of common stock)
Private placement of common stock
Jul 31, 2025
Announced: US$10M
Buyers: Medtronic ($10 million of common stock)
Secured subordinated promissory note convertible to prepaid revenue share
Jul 31, 2025
Announced: US$20M
Buyers: Medtronic ($20 million secured subordinated promissory note)
Decks
Investor Presentation (October 2026)
Investor deck · 30 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 26 slides · Sep 8, 2026
Technical Presentation (2026)
Technical · 12 slides · 2026
CRT 2026
Conference · 13 slides · 2026
Orchestra BioMed Holdings, Inc. on 6ix
- News releases
- 24 in the last 12 months · 80 in all · newest Nov 6, 2026 · oldest 2022
- Decks
- 21 decks · latest October 2026
Where Orchestra BioMed Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:OBIO · Home listing | NASDAQ | United States | USD |
| BOATS:OBIO · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Orchestra BioMed Holdings, Inc.